Biggest changeNon-GAAP Measures Reconciliation of Net Income to EBITDA and Adjusted EBITDA Year Ended December 31, 2024 2023 2022 Revenues before reimbursable expenses $ 1,486,085 $ 1,362,060 $ 1,132,455 Reimbursable expenses 35,720 36,695 26,506 Total revenues $ 1,521,805 $ 1,398,755 $ 1,158,961 Net income $ 116,626 $ 62,479 $ 75,552 Net income as a percentage of total revenues 7.7 % 4.5 % 6.5 % Add back: Income tax expense 37,390 21,416 33,025 Interest expense, net of interest income 25,347 19,573 11,883 Depreciation and amortization 25,663 25,672 28,233 EBITDA 205,026 129,140 148,693 Add back: Restructuring charges 9,913 11,550 9,909 2024 litigation settlement gain (11,701) — — Other losses (gains), net 804 (444) (193) Transaction-related expenses 2,861 357 50 Unrealized loss (gain) on preferred stock investment — 26,262 (26,964) Gain on sale of business (3,597) — — Foreign currency transaction losses (gains), net (2,138) 476 (655) Adjusted EBITDA $ 201,168 $ 167,341 $ 130,840 Adjusted EBITDA as a percentage of revenues before reimbursable expenses 13.5 % 12.3 % 11.6 % 27 Table of Contents Reconciliation of Net Income to Adjusted Net Income and Adjusted Diluted Earnings per Share Year Ended December 31, 2024 2023 2022 Net income $ 116,626 $ 62,479 $ 75,552 Weighted average shares - diluted 18,613 19,601 20,746 Diluted earnings per share $ 6.27 $ 3.19 $ 3.64 Add back: Amortization of intangible assets 6,517 8,219 11,198 Restructuring charges 9,913 11,550 9,909 2024 litigation settlement gain (11,701) — — Other losses (gains), net 804 (444) (193) Transaction-related expenses 2,861 357 50 Unrealized loss (gain) on preferred stock investment — 26,262 (26,964) Gain on sale of business (3,597) — — Tax effect of adjustments (977) (12,175) 1,590 Total adjustments, net of tax 3,820 33,769 (4,410) Adjusted net income $ 120,446 $ 96,248 $ 71,142 Adjusted weighted average shares - diluted 18,613 19,601 20,746 Adjusted diluted earnings per share $ 6.47 $ 4.91 $ 3.43 Year Ended December 31, 2024 Compared to Year Ended December 31, 2023 Revenues before Reimbursable Expenses Revenues before reimbursable expenses by segment and capability for the years ended December 31, 2024 and 2023 were as follows: Revenues before Reimbursable Expenses (in thousands) Year Ended December 31, Increase / (Decrease) 2024 2023 $ % Segment: Healthcare $ 756,263 $ 673,989 $ 82,274 12.2 % Education 474,221 429,663 44,558 10.4 % Commercial 255,601 258,408 (2,807) (1.1) % Total revenues before reimbursable expenses $ 1,486,085 $ 1,362,060 $ 124,025 9.1 % Capability: Consulting and Managed Services $ 863,859 $ 782,020 $ 81,839 10.5 % Digital 622,226 580,040 42,186 7.3 % Total revenues before reimbursable expenses $ 1,486,085 $ 1,362,060 $ 124,025 9.1 % Revenues before reimbursable expenses increased $124.0 million, or 9.1%, to $1.49 billion for the year ended December 31, 2024 from $1.36 billion for the year ended December 31, 2023.
Biggest changeWe do not present utilization rates for our Managed Services professionals as most of the revenues generated by these employees are not billed on an hourly basis. 27 Table of Contents Non-GAAP Measures Reconciliation of Net Income to EBITDA and Adjusted EBITDA Year Ended December 31, 2025 2024 2023 Revenues before reimbursable expenses $ 1,662,836 $ 1,486,085 $ 1,362,060 Reimbursable expenses 36,307 35,720 36,695 Total revenues $ 1,699,143 $ 1,521,805 $ 1,398,755 Net income $ 105,040 $ 116,626 $ 62,479 Net income as a percentage of total revenues 6.2 % 7.7 % 4.5 % Add back: Income tax expense 30,040 37,390 21,416 Interest expense, net of interest income 34,197 25,347 19,573 Depreciation and amortization 32,478 25,663 25,672 EBITDA 201,755 205,026 129,140 Add back: Restructuring charges 9,136 9,913 11,550 2024 litigation settlement gain — (11,701) — Other losses (gains), net 3,072 804 (444) Transaction-related expenses 8,521 2,861 357 Unrealized losses on long-term investments, net 15,396 — 26,262 Gain on sale of business — (3,597) — Foreign currency transaction losses (gains), net (363) (2,138) 476 Adjusted EBITDA $ 237,517 $ 201,168 $ 167,341 Adjusted EBITDA as a percentage of revenues before reimbursable expenses 14.3 % 13.5 % 12.3 % Reconciliation of Net Income to Adjusted Net Income and Adjusted Diluted Earnings per Share Year Ended December 31, 2025 2024 2023 Net income $ 105,040 $ 116,626 $ 62,479 Weighted average shares - diluted 17,991 18,613 19,601 Diluted earnings per share $ 5.84 $ 6.27 $ 3.19 Add back: Amortization of intangible assets 11,334 6,517 8,219 Restructuring charges 9,136 9,913 11,550 2024 litigation settlement gain — (11,701) — Other losses (gains), net 3,072 804 (444) Transaction-related expenses 8,521 2,861 357 Unrealized losses on long-term investments, net 15,396 — 26,262 Gain on sale of business — (3,597) — Tax effect of adjustments (11,654) (977) (12,175) Total adjustments, net of tax 35,805 3,820 33,769 Adjusted net income $ 140,845 $ 120,446 $ 96,248 Adjusted weighted average shares - diluted 17,991 18,613 19,601 Adjusted diluted earnings per share $ 7.83 $ 6.47 $ 4.91 28 Table of Contents Year Ended December 31, 2025 Compared to Year Ended December 31, 2024 Revenues before Reimbursable Expenses Revenues before reimbursable expenses by segment and capability for the years ended December 31, 2025 and 2024 were as follows: Revenues before Reimbursable Expenses (in thousands) Year Ended December 31, Increase / (Decrease) 2025 2024 $ % Segment: Healthcare $ 837,537 $ 756,263 $ 81,274 10.7 % Education 500,174 474,221 25,953 5.5 % Commercial 325,125 255,601 69,524 27.2 % Total revenues before reimbursable expenses $ 1,662,836 $ 1,486,085 $ 176,751 11.9 % Capability: Consulting and Managed Services $ 976,883 $ 863,859 $ 113,024 13.1 % Digital 685,953 622,226 63,727 10.2 % Total revenues before reimbursable expenses $ 1,662,836 $ 1,486,085 $ 176,751 11.9 % Revenues before reimbursable expenses increased $176.8 million, or 11.9%, to $1.66 billion for the year ended December 31, 2025 from $1.49 billion for the year ended December 31, 2024.
Changes in the market value of our deferred compensation liability are offset with the changes in market value of investments that are used to fund our deferred compensation liability, which are recorded within other income (expense), net.
Changes in the market value of our deferred compensation liability are offset with the changes in market value of the investments that are used to fund our deferred compensation liability, which are recorded within other income (expense), net.
Income Tax Expense For the year ended December 31, 2024, our effective tax rate was 24.3% as we recognized income tax expense of $37.4 million on income of $154.0 million.
For the year ended December 31, 2024, our effective tax rate was 24.3% as we recognized income tax expense of $37.4 million on income of $154.0 million.
Under GAAP, we have the option to first assess qualitative factors to determine whether the existence of current events or circumstances would lead to a determination that it is more likely than not that the fair value of one of our reporting units is greater than its carrying value.
Under GAAP, we have the option to first assess qualitative factors to determine whether the existence of current events or circumstances would lead to a determination that it is more likely than not that the fair value of one or more of our reporting units is greater than its carrying value.
Losses (gains) on sale of business: We exclude the effect of non-operating losses and gains recognized as a result of sales of businesses as they are infrequent, management believes that these items are not indicative of the ongoing performance of our business, and their exclusion permits comparability with periods that were not impacted by such items.
Losses (gains) on sales of businesses: We exclude the effect of non-operating losses and gains recognized as a result of sales of businesses as they are infrequent, management believes that these items are not indicative of the ongoing performance of our business, and their exclusion permits comparability with periods that were not impacted by such items.
Revenue-Generating Professionals Our revenue-generating professionals consist of our full-time consultants who generate revenues based on the number of hours worked; full-time equivalents, which consists of coaches and their support staff within the culture and organizational excellence solution, consultants who work variable schedules as needed by clients, and full-time employees who provide software support and maintenance services to clients; 23 Table of Contents and our Managed Services professionals who provide revenue cycle management and research administration managed services and outsourcing at our healthcare, education and research-focused clients.
Revenue-Generating Professionals Our revenue-generating professionals consist of our full-time consultants who generate revenues based on the number of hours worked; full-time equivalents, which consists of coaches and their support staff within the culture and organizational excellence solution, consultants who work variable schedules as needed by clients, and full-time employees who provide software support and maintenance services to clients; 24 Table of Contents and our Managed Services professionals who provide revenue cycle management and research administration managed services and outsourcing at our healthcare, education and research-focused clients.
A reporting unit is an operating segment or one level below an operating segment (referred to as a component) to which goodwill is assigned when initially recorded. We assign goodwill to reporting units based on our integration plans and the expected synergies resulting from the acquisition. As of December 31, 2024, we have three reporting units: Healthcare, Education, and Commercial.
A reporting unit is an operating segment or one level below an operating segment (referred to as a component) to which goodwill is assigned when initially recorded. We assign goodwill to reporting units based on our integration plans and the expected synergies resulting from the acquisition. As of December 31, 2025, we have three reporting units: Healthcare, Education, and Commercial.
Fees and interest on borrowings under the Amended Credit Agreement vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, these borrowings will bear interest at one, three or six month Term SOFR or, in the case of the Revolver, an alternate base rate, in each case plus the applicable margin.
Fees and interest on borrowings under the Amended Credit Agreement vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, these borrowings will bear interest at one, three or six month Term SOFR or an alternate base rate, in each case plus the applicable margin.
The gains recognized in 2024 and 2023 related to the market value of our investments that are used to fund our deferred compensation liability were offset with deferred compensation expense attributable to the change in the market value of our deferred compensation liability which is recognized as a component of selling, general and administrative expenses on our consolidated statements of operations.
The gains recognized in 2025 and 2024 related to the market value of our investments that are used to fund our deferred compensation liability were offset with deferred compensation expense attributable to the change in the market value of our deferred compensation liability which is recognized as a component of selling, general and administrative expenses on our consolidated statements of operations.
Selling, general and administrative expenses consist primarily of compensation costs for our support personnel, which includes salaries, performance bonuses, share-based compensation, signing and retention bonuses, payroll taxes, benefits and deferred compensation expense attributable to the change in market value of our deferred compensation liability.
Selling, general and administrative expenses primarily consists of compensation costs for our support personnel, which includes salaries, performance bonuses, share-based compensation, signing and retention bonuses, payroll taxes, benefits and deferred compensation expense attributable to the change in market value of our deferred compensation liability.
For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At December 31, 2024 and December 31, 2023, we were in compliance with these financial covenants.
For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At December 31, 2025 and December 31, 2024, we were in compliance with these financial covenants.
For a discussion of certain risks and uncertainties related to the Current Credit Agreement, see Part I—Item 1A. “Risk Factors.” Future Financing Needs Our primary financing need is to fund our long-term growth.
For a discussion of certain risks and uncertainties related to the Amended Credit Agreement, see Part I—Item 1A. “Risk Factors.” Future Financing Needs Our primary financing need is to fund our long-term growth.
The outcome of these final determinations could have a material impact on our provision for taxes, net income, or cash flows in the period in which that determination is made. 38 Table of Contents NEW ACCOUNTING PRONOUNCEMENTS Refer to Note 2 “Summary of Significant Accounting Policies” within the notes to the consolidated financial statements for information on new accounting pronouncements.
The outcome of these final determinations could have a material impact on our provision for taxes, net income, or cash flows in the period in which that determination is made. NEW ACCOUNTING PRONOUNCEMENTS Refer to Note 2 “Summary of Significant Accounting Policies” within the notes to the consolidated financial statements for information on new accounting pronouncements.
We generate our revenues before reimbursable expenses from providing professional services and software products under the following four types of billing arrangements: fixed-fee (including software license revenue); time-and-expense; performance-based; and software support, maintenance and subscriptions. • Fixed-fee (including software license revenue): In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services.
We generate our revenues before reimbursable expenses from providing professional services and software products under the following four types of billing arrangements: fixed-fee; time-and-expense; performance-based; and software support, maintenance and subscriptions. • Fixed-fee: In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services.
Also included in selling, general and administrative expenses are third-party professional fees, software licenses and data hosting expenses, rent and other office related expenses, sales and marketing related expenses, recruiting and training expenses, and practice administration and meetings expenses.
Also included in selling, general and administrative expenses are third-party professional fees, software licenses and data hosting expenses, rent and other office-related expenses, sales and marketing-related expenses, recruiting and training expenses, and practice administration and meeting expenses.
The increase in net cash provided by operating activities primarily related to an increase in cash collections in 2024, a $15 million litigation settlement received in 2024 for a completed legal matter in which Huron was the plaintiff, and a decrease in payments for contractor expenses in 2024 compared to 2023; partially offset by an increase in payments for salaries and related expenses for our revenue-generating professionals, an increase in the amount paid for annual performance bonuses in the first quarter of 2024 compared to the first quarter of 2023, and an increase in payments for selling, general and administrative expenses in 2024 compared to the prior year.
The decrease in net cash provided by operating activities primarily related to an increase in payments for salaries and related expenses for our revenue-generating professionals, an increase in payments for selling, general and administrative expenses, a $15 million litigation settlement received in 2024 for a completed legal matter in which Huron was the plaintiff, an increase in the amount paid for annual performance bonuses in the first quarter of 2025 compared to the first quarter of 2024, and an increase in payments for contractor expenses; largely offset by an increase in cash collections in 2025 compared to the prior year.
We evaluate our intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. No impairment charges for intangible assets were recorded in 2024.
We evaluate our intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. No impairment charges for intangible assets were recorded in 2025.
The following information summarizes our results of operations for 2024, 2023 and 2022; and discusses those results of operations for 2024 compared to 2023. For a discussion of our results of operations for 2023 compared to 2022 refer to Part II—Item 7.
The following information summarizes our results of operations for 2025, 2024 and 2023; and discusses those results of operations for 2025 compared to 2024. For a discussion of our results of operations for 2024 compared to 2023 refer to Part II—Item 7.
Third-party legal costs incurred for this litigation matter in 2023 and 2022 were $4.0 million and $2.0 million, respectively. Our third-party legal expenses are recorded as a component of selling, general and administrative expenses on our statement of operations.
Third-party legal costs incurred for this litigation matter in 2023 were $4.0 million. Our third-party legal expenses are recorded as a component of selling, general and administrative expenses on our statement of operations.
“ Management’s Discussion and Analysis of Financial Condition and Results of Operations ” of the Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the United States Securities and Exchange Commission on February 27, 2024.
“ Management’s Discussion and Analysis of Financial Condition and Results of Operations ” of the Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the United States Securities and Exchange Commission on February 25, 2025.
As of December 31, 2024 and 2023, the unused borrowing capacity under the Revolver was $506.6 million and $275.5 million, respectively. Refer to Note 7 “Financing Arrangements” for additional information on our senior secured credit facility within the notes to the consolidated financial statements.
As of December 31, 2025 and 2024, the unused borrowing capacity under the Revolver was $578.6 million and $506.6 million, respectively. Refer to Note 7 “Financing Arrangements” within the notes to the consolidated financial statements for additional information on our senior secured credit facility.
The borrowing capacity under the Revolver is reduced by any outstanding borrowings under the agreement and outstanding letters of credit. At December 31, 2024 and 2023, we had outstanding letters of credit totaling $0.4 million and $0.5 million, respectively, which are used as security deposits for our office facilities.
The borrowing capacity under the Revolver is reduced by any outstanding borrowings under the agreement and outstanding letters of credit. At both December 31, 2025 and 2024, we had outstanding letters of credit totaling $0.4 million, which are used as security deposits for our office facilities.
We include, within the depreciation and amortization adjustment, the amortization of capitalized implementation costs of our ERP and other related software, which is included within selling, general and administrative expenses in our consolidated statements of operations.
We include, within the depreciation and amortization adjustment, the amortization of capitalized implementation costs of our enterprise resource planning (ERP) system and other related software, which is included within selling, general and administrative expenses in our consolidated statements of operations.
See Note 13 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on the fair value of contingent consideration liabilities. Restructuring Charges Restructuring charges for the year ended December 31, 2024 were $9.9 million, compared to $11.6 million for the year ended December 31, 2023.
See Note 13 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on the fair value of contingent consideration liabilities. Restructuring Charges Restructuring charges for the year ended December 31, 2025 were $9.1 million, compared to $9.9 million for the year ended December 31, 2024.
These borrowings carried a weighted average interest rate of 4.7% at December 31, 2024 and 4.2% at December 31, 2023 including the impact of the interest rate swaps described in Note 12 “Derivative Instruments and Hedging Activity" within the notes to the consolidated financial statements.
These borrowings carried a weighted average interest rate of 5.3% at December 31, 2025 and 4.7% at December 31, 2024 including the impact of the interest rate swaps described in Note 12 “Derivative Instruments and Hedging Activity" within the notes to the consolidated financial statements.
Our investments include a convertible note investment in Shorelight Holdings, LLC, a preferred stock investment in a hospital-at-home company, and investments in life insurance policies that are used to fund our deferred compensation liability.
Our investments include a convertible note investment in Shorelight Holdings, LLC, an equity investment in a hospital-at-home company, and investments in life insurance policies that are used to fund our deferred compensation liability.
Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions.
Management also uses these non-GAAP financial measures when publicly providing our business 23 Table of Contents outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions.
The applicable margin for borrowings under the Revolver will fluctuate between 1.125% per annum and 1.875% per annum, in the case of Term SOFR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.
The applicable margin will fluctuate between 1.250% per annum and 1.875% per annum, in the case of Term SOFR borrowings, or between 0.250% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.
The increase in adjusted EBITDA was primarily attributable to the increases in Healthcare and Education operating income, excluding the impact of segment depreciation and amortization and segment restructuring charges; partially offset by the increase in unallocated corporate expenses, excluding the impacts of the change in the market value of our deferred compensation liability and transaction-related expenses.
The increase in adjusted EBITDA was primarily attributable to the increases in segment operating income for all three of our segments, excluding the impact of segment depreciation and amortization and segment restructuring charges; partially offset by the increase in unallocated corporate expenses, excluding the impacts of the change in the market value of our deferred compensation liability and transaction-related expenses.
Our intangible assets, net of accumulated amortization, totaled $26.1 million at December 31, 2024 and primarily consist of customer relationships, technology and software, trade names, customer contracts, and non-competition agreements, all of which were acquired through business combinations.
Our intangible assets, net of accumulated amortization, totaled $72.9 million at December 31, 2025 and primarily consist of customer relationships, technology and software, trade names, customer contracts, and non-competition agreements, all of which were acquired through business combinations.
The increases in compensation costs for our revenue-generating professionals and support personnel were primarily driven by an increase in headcount and annual salary increases that went into effect in the first quarter of 2024; partially offset by decreases in performance bonus expense and share-based compensation expense for our revenue-generating professionals.
The increases in compensation costs for our revenue-generating professionals and support personnel were primarily driven by an increase in headcount and annual salary increases that went into effect in the first quarter of 2025, partially offset by a decrease in performance bonus expense for our revenue-generating professionals.
(5) Managed Services capability revenues before reimbursable expenses within our Healthcare segment was $77.5 million, $70.1 million and $67.6 million for the years ended 2024, 2023 and 2022, respectively. Managed Services capability revenues before reimbursable expenses within our Education segment was $28.2 million, $29.6 million and $30.6 million for the years ended 2024, 2023 and 2022, respectively.
(4) Managed Services capability revenues before reimbursable expenses within our Healthcare segment was $90.1 million, $77.5 million and $70.1 million for the years ended 2025, 2024 and 2023, respectively. Managed Services capability revenues before reimbursable expenses within our Education segment was $29.3 million, $28.2 million and $29.6 million for the years ended 2025, 2024 and 2023, respectively.
The utilization rate within our Consulting capability decreased to 73.6% in 2024, compared to 76.6% in 2023. Revenues before reimbursable expenses within our Digital capability increased 7.3% to $622.2 million in 2024, compared to $580.0 million in 2023; and reflected strengthened demand in our Healthcare and Education segments, partially offset by a decrease in demand in our Commercial segment.
The utilization rate within our Consulting capability increased to 75.7% in 2025, compared to 73.6% in 2024. Revenues before reimbursable expenses within our Digital capability increased 10.2% to $686.0 million in 2025, compared to $622.2 million in 2024; and reflected strengthened demand in our Commercial and Education segments, partially offset by a decrease in demand in our Healthcare segment.
See “Liquidity and Capital Resources” below and Note 7 “Financing Arrangements” within the notes to our consolidated financial statements for additional information about our senior secured credit facility. Other income (expense), net increased $32.4 million to income of $10.5 million for the year ended December 31, 2024 from expense of $21.9 million for the year ended December 31, 2023.
See “Liquidity and Capital Resources” below and Note 7 “Financing Arrangements” within the notes to our consolidated financial statements for additional information about our senior secured credit facility. Other income (expense), net totaled expense of $9.3 million for the year ended December 31, 2025, compared to income of $10.5 million for the year ended December 31, 2024.
To the extent we write-off accounts receivable due to a client’s inability to pay, the charge is recognized as a component of selling, general and administrative expenses. Business Combinations We use the acquisition method of accounting for business combinations .
We record the provision for doubtful accounts and unbilled services as a reduction in revenue. To the extent we write-off accounts receivable due to a client’s inability to pay, the charge is recognized as a component of selling, general and administrative expenses. Business Combinations We use the acquisition method of accounting for business combinations .
We set the fees based on our estimates of the costs and timing for completing the engagements. Fixed-fee arrangements also include software licenses for our research administration and compliance software. • Time-and-expense: Under time-and-expense billing arrangements, we invoice our clients based on the number of hours worked by our revenue-generating professionals at agreed upon rates.
We set the fees based on our estimates of the costs and timing for completing the engagements. • Time-and-expense: Under time-and-expense billing arrangements, we invoice our clients based on the number of hours worked by our revenue-generating professionals at agreed upon rates.
The increase in compensation costs for our revenue-generating professionals was primarily driven by annual salary increases that went into effect in the first quarter of 2024 and an increase in headcount due to the acquisition of AXIA Consulting in the fourth quarter of 2024; partially offset by decreases in signing, retention and other bonus expense and performance bonus expense for our revenue-generating professionals.
The increase in compensation costs for our revenue-generating professionals was primarily due to the increased headcount, driven by our acquisitions of AXIA Consulting and Treliant, annual salary increases that went into effect in the first quarter of 2025, and increases in performance bonus expense and signing, retention and other bonus expense.
Cash Flows (in thousands): Year Ended December 31, 2024 2023 2022 Net cash provided by operating activities $ 201,319 $ 135,262 $ 85,400 Net cash used in investing activities (79,749) (36,652) (20,128) Net cash used in financing activities (111,635) (98,327) (74,108) Effect of exchange rate changes on cash (173) 32 (111) Net increase (decrease) in cash and cash equivalents $ 9,762 $ 315 $ (8,947) Operating Activities Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, accrued payroll and related benefits, operating lease obligations and deferred revenues.
Cash Flows (in thousands): Year Ended December 31, 2025 2024 2023 Net cash provided by operating activities $ 193,394 $ 201,319 $ 135,262 Net cash used in investing activities (145,751) (79,749) (36,652) Net cash used in financing activities (45,030) (111,635) (98,327) Effect of exchange rate changes on cash (16) (173) 32 Net increase in cash and cash equivalents $ 2,597 $ 9,762 $ 315 Operating Activities Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, accrued payroll and related benefits, operating lease obligations and deferred revenues.
Other Income (Expense), Net Interest expense, net of interest income increased $5.8 million to $25.3 million for the year ended December 31, 2024 from $19.6 million for the year ended December 31, 2023, which was primarily attributable to higher levels of borrowing and higher interest rates under our Amended Credit Facility in 2024 compared to 2023.
Other Income (Expense), Net Interest expense, net of interest income increased $8.9 million to $34.2 million for the year ended December 31, 2025 from $25.3 million for the year ended December 31, 2024, which was primarily attributable to higher levels of borrowing and higher interest rates under our senior secured credit facility in 2025 compared to 2024.
Our ability to secure additional financing in the future, if needed, will depend on several factors, including our future profitability, the quality of our accounts receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets.
Our ability to secure additional financing in the future, if needed, will depend on several factors, including our future profitability, the quality of our accounts receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets. OFF-BALANCE SHEET ARRANGEMENTS We are not a party to any material off-balance sheet arrangements.
The effective tax rate of 25.5% was more favorable than the statutory rate, inclusive of state income taxes, of 26.2%, primarily due to a discrete tax benefit for share-based compensation awards that vested during the year and the positive impact of certain federal tax credits. These favorable items were partially offset by certain nondeductible expense items.
The effective tax rate of 22.2% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to a discrete tax benefit for share-based compensation awards that vested during the year. This favorable item was partially offset by certain nondeductible expense items.
The increases in compensation costs for our revenue-generating professionals were primarily driven by an increase in headcount and annual salary increases that went into effect in the first quarter of 2024, an increase in performance bonus expense, and an increase in share-based compensation expenses; partially offset by a decrease in signing, retention and other bonus expense.
The increases in compensation costs for our revenue-generating professionals were primarily driven by an increase in headcount and annual salary increases that went into effect in the first quarter of 2025, as well as increases in 31 Table of Contents performance bonus expense, signing, retention and other bonus expense, and share-based compensation expense.
These multiples are evaluated and adjusted based on specific characteristics of the reporting units relative to the selected guideline companies and applied to the reporting units' operating data to arrive at an indication of value.
These multiples are evaluated and adjusted based on specific characteristics of the reporting units relative to the selected guideline companies and applied to the reporting units' operating data to arrive at an indication of value. The following is a discussion of the goodwill impairment test performed during 2025.
Specifically, multiple performance obligation arrangements require us to allocate the total transaction price to each performance obligation based on its relative standalone selling price, for which we rely on our overall pricing objectives, taking into consideration market conditions and other factors.
Determining the method and amount of revenue to recognize requires us to make judgments and estimates. 36 Table of Contents Specifically, multiple performance obligation arrangements require us to allocate the total transaction price to each performance obligation based on its relative standalone selling price, for which we rely on our overall pricing objectives, taking into consideration market conditions and other factors.
See Note 17 “Income Taxes” within the notes to our consolidated financial statements for additional information on our income tax expense. Net Income and Earnings per Share Net income increased $54.1 million to $116.6 million for the year ended December 31, 2024 from $62.5 million for the year ended December 31, 2023.
See Note 17 “Income Taxes” within the notes to our consolidated financial statements for additional information on our income tax expense. Net Income and Earnings per Share Net income decreased $11.6 million, or 9.9%, to $105.0 million for the year ended December 31, 2025 from $116.6 million for the year ended December 31, 2024.
Revenue Recognition We generate substantially all of our revenues from providing professional services to our clients. We also generate revenues from software licenses, software support and maintenance and subscriptions to our cloud-based analytic tools and solutions, speaking engagements, conferences, and publications.
Revenue Recognition We generate substantially all of our revenues from providing professional services to our clients. We also generate revenues from software licenses, software support and maintenance and subscriptions to our cloud-based analytic tools and solutions, speaking engagements, conferences, and publications. Our revenue is generated under four types of billing arrangements: fixed-fee; time-and-expense; performance-based; and software support, maintenance and subscriptions.
As a percentage of revenues before reimbursable expenses, selling, general and administrative expenses increased to 19.3% during 2024, compared to 18.9% during 2023.
As a percentage of revenues before reimbursable expenses, selling, general and administrative expenses decreased to 19.1% during 2025, compared to 19.3% during 2024.
Diluted earnings per share for the year ended December 31, 2024 increased to $6.27, compared to $3.19 for the year ended December 31, 2023, driven by the increase in net income and a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan.
Diluted earnings per share for the year ended December 31, 2025 decreased to $5.84, compared to $6.27 for the year ended December 31, 2024, driven by the decrease in net income, partially offset by a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan.
See “Financing Arrangements” below for additional information on our senior secured credit facility. Net cash used in financing activities was $111.6 million in 2024. During 2024, we borrowed $743.5 million and made repayments on our borrowings of $709.8 million.
Net cash used in financing activities was $111.6 million in 2024. During 2024, we borrowed $743.5 million and made repayments on our borrowings of $709.8 million.
OFF-BALANCE SHEET ARRANGEMENTS We are not a party to any material off-balance sheet arrangements. 35 Table of Contents CRITICAL ACCOUNTING POLICIES AND ESTIMATES Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
CRITICAL ACCOUNTING POLICIES AND ESTIMATES Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).
Revenues before reimbursable expenses increased $124.0 million, or 9.1%, to $1.49 billion for the year ended December 31, 2024 from $1.36 billion for the year ended December 31, 2023.
Revenues before reimbursable expenses increased $176.8 million, or 11.9%, to $1.66 billion for the year ended December 31, 2025 from $1.49 billion for the year ended December 31, 2024.
As a percentage of revenues before reimbursable expenses, direct costs decreased to 68.0% during 2024, compared to 69.2% during 2023, primarily attributable to the decrease in contractor expenses and revenue growth that outpaced the increase in performance bonus expense for our revenue-generating professionals; partially offset by an increase in salaries and related expenses for our revenue-generating professionals, as a percentage of revenues before reimbursable expenses.
As a percentage of revenues before reimbursable expenses, direct costs decreased to 67.5% during 2025, compared to 68.0% during 2024, primarily attributable to revenue growth that outpaced the increase in performance bonus expense for our revenue-generating professionals.
(7) The number of Managed Services professionals within our Healthcare segment was 1,420, 924 and 715 as of December 31, 2024, 2023 and 2022, respectively. 26 Table of Contents The number of Managed Services professionals within our Education segment was 110, 126 and 160 as of December 31, 2024, 2023 and 2022, respectively.
The number of Managed Services professionals within our Healthcare segment was 2,117, 1,420 and 924 as of December 31, 2025, 2024 and 2023, respectively. The number of Managed Services professionals within our Education segment was 122, 110 and 126 as of December 31, 2025, 2024 and 2023, respectively.
Selling, General and Administrative Expenses Selling, general and administrative expenses increased by $28.7 million, or 11.1%, to $286.7 million for the year ended December 31, 2024 from $257.9 million for the year ended December 31, 2023.
Selling, General and Administrative Expenses Selling, general and administrative expenses increased by $31.4 million, or 10.9%, to $318.0 million for the year ended December 31, 2025 from $286.7 million for the year ended December 31, 2024.
The $0.4 million of other gains, net for the year ended December 31, 2023 primarily consisted of net remeasurement gains to decrease the fair value of our contingent consideration liabilities related to business combinations.
The $3.1 million of other losses, net for the year ended December 31, 2025 primarily consisted of net remeasurement charges to increase the fair value of our contingent consideration liabilities related to business combinations.
Additionally, restructuring charges incurred in 2023 included $3.0 million of severance-related expenses; $1.8 million for rent and related expenses, net of sublease income, for previously vacated office spaces; $0.9 million related to non-cash lease impairment charges driven by updated sublease assumptions for previously vacated office spaces; and $0.3 million related to the abandonment of a capitalized software development project.
Restructuring charges incurred in 2024 also included $2.3 million of severance-related expenses unrelated to the divestiture; $2.3 million of rent and related expenses, net of sublease income, for previously vacated office spaces; and $0.8 million related to non-cash lease impairment charges driven by updated sublease assumptions for our previously vacated office spaces.
As a result of the increase in net income and a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan, diluted earnings per share increased 96.6% to $6.27 for 2024, compared to $3.19 for 2023.
As a result of the decrease in net income, and partially offset by a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan, diluted earnings per share decreased 6.9% to $5.84 for 2025, compared to $6.27 for 2024.
Segment and Consolidated Operating Results (in thousands, except per share amounts): Year Ended December 31, 2024 2023 2022 Healthcare: Revenues before reimbursable expenses $ 756,263 $ 673,989 $ 534,999 Operating income $ 208,928 $ 172,900 $ 131,227 Segment operating income as a percentage of segment revenues before reimbursable expenses 27.6 % 25.7 % 24.5 % Education: Revenues before reimbursable expenses $ 474,221 $ 429,663 $ 359,835 Operating income $ 108,521 $ 99,098 $ 78,924 Segment operating income as a percentage of segment revenues before reimbursable expenses 22.9 % 23.1 % 21.9 % Commercial: Revenues before reimbursable expenses $ 255,601 $ 258,408 $ 237,621 Operating income $ 51,198 $ 54,202 $ 50,025 Segment operating income as a percentage of segment revenues before reimbursable expenses 20.0 % 21.0 % 21.1 % Total Huron: Revenues before reimbursable expenses $ 1,486,085 $ 1,362,060 $ 1,132,455 Reimbursable expenses 35,720 36,695 26,506 Total revenues $ 1,521,805 $ 1,398,755 $ 1,158,961 Items not allocated at the segment level: Unallocated corporate expenses 191,180 175,206 136,459 Other gains, net (14,466) (444) (218) Restructuring charges 7,590 8,204 3,686 Depreciation and amortization 15,524 17,886 20,271 Operating income 168,819 125,348 99,760 Other income (expense), net (14,803) (41,453) 8,817 Income before taxes 154,016 83,895 108,577 Income tax expense 37,390 21,416 33,025 Net income $ 116,626 $ 62,479 $ 75,552 Earnings per share Basic $ 6.52 $ 3.32 $ 3.73 Diluted $ 6.27 $ 3.19 $ 3.64 25 Table of Contents Segment and Consolidated Operating Results (in thousands, except per share amounts): Year Ended December 31, 2024 2023 2022 Other Operating Data: Number of revenue-generating professionals by segment (at period end) (1) : Healthcare 1,218 1,126 1,004 Education 1,141 1,080 837 Commercial (2) 2,335 2,263 2,116 Total (excluding Managed Services) 4,694 4,469 3,957 Managed Services (3) 1,530 1,050 875 Total 6,224 5,519 4,832 Revenues before reimbursable expenses by capability: Consulting and Managed Services (4)(5) $ 863,859 $ 782,020 $ 637,994 Digital 622,226 580,040 494,461 Total $ 1,486,085 $ 1,362,060 $ 1,132,455 Number of revenue-generating professionals by capability (at period end) (6) : Consulting (4)(7) 1,729 1,598 1,419 Managed Services (4)(7) 1,530 1,050 875 Digital 2,965 2,871 2,538 Total 6,224 5,519 4,832 Utilization rate by capability (8) : Consulting 73.6% 76.6% 75.2% Digital 76.0% 75.3% 71.0% (1) During the first quarter of 2024, we reclassified certain revenue-generating professionals within our Digital capability from our Healthcare and Education segments to our Commercial segment as these professionals are able to provide services across all of our industries.
Segment and Consolidated Operating Results (in thousands, except per share amounts): Year Ended December 31, 2025 2024 2023 Healthcare: Revenues before reimbursable expenses $ 837,537 $ 756,263 $ 673,989 Operating income $ 255,582 $ 208,928 $ 172,900 Segment operating income as a percentage of segment revenues before reimbursable expenses 30.5 % 27.6 % 25.7 % Education: Revenues before reimbursable expenses $ 500,174 $ 474,221 $ 429,663 Operating income $ 113,186 $ 108,521 $ 99,098 Segment operating income as a percentage of segment revenues before reimbursable expenses 22.6 % 22.9 % 23.1 % Commercial: Revenues before reimbursable expenses $ 325,125 $ 255,601 $ 258,408 Operating income $ 55,857 $ 51,198 $ 54,202 Segment operating income as a percentage of segment revenues before reimbursable expenses 17.2 % 20.0 % 21.0 % Total Huron: Revenues before reimbursable expenses $ 1,662,836 $ 1,486,085 $ 1,362,060 Reimbursable expenses 36,307 35,720 36,695 Total revenues $ 1,699,143 $ 1,521,805 $ 1,398,755 Items not allocated at the segment level: Unallocated corporate expenses 217,564 191,180 175,206 Other losses (gains), net 2,968 (14,466) (444) Restructuring charges 6,035 7,590 8,204 Depreciation and amortization 19,488 15,524 17,886 Operating income 178,570 168,819 125,348 Other income (expense), net (43,490) (14,803) (41,453) Income before taxes 135,080 154,016 83,895 Income tax expense 30,040 37,390 21,416 Net income $ 105,040 $ 116,626 $ 62,479 Earnings per share Basic $ 6.02 $ 6.52 $ 3.32 Diluted $ 5.84 $ 6.27 $ 3.19 26 Table of Contents Segment and Consolidated Operating Results (in thousands, except per share amounts): Year Ended December 31, 2025 2024 2023 Other Operating Data: Number of revenue-generating professionals by segment (at period end): Healthcare 1,493 1,218 1,126 Education 1,145 1,141 1,080 Commercial (1)(2) 2,669 2,335 2,263 Total (excluding Managed Services) 5,307 4,694 4,469 Managed Services (3) 2,239 1,530 1,050 Total 7,546 6,224 5,519 Revenues before reimbursable expenses by capability: Consulting and Managed Services (4) $ 976,883 $ 863,859 $ 782,020 Digital 685,953 622,226 580,040 Total $ 1,662,836 $ 1,486,085 $ 1,362,060 Number of revenue-generating professionals by capability (at period end): Consulting 2,215 1,729 1,598 Managed Services (3) 2,239 1,530 1,050 Digital 3,092 2,965 2,871 Total 7,546 6,224 5,519 Utilization rate by capability (5) : Consulting 75.7% 73.6% 76.6% Digital 78.2% 76.0% 75.3% (1) The majority of our revenue-generating professionals within our Commercial segment can provide services across all of our industries, including healthcare and education.
Additional information on our revenues before reimbursable expense by segment follows. 28 Table of Contents • Healthcare revenues before reimbursable expenses increased $82.3 million, or 12.2%, driven by continued strength in demand for our performance improvement, revenue cycle managed services, culture and organizational excellence and strategy and innovation solutions within our Consulting and Managed Services capability and our technology and analytics services within our Digital capability.
Additional information on our revenues before reimbursable expense by segment follows. • Healthcare revenues before reimbursable expenses increased $81.3 million, or 10.7%, driven by continued strength in demand for our performance improvement, financial advisory, revenue cycle managed services and strategy and innovation solutions within our Consulting and Managed Services capability.
Share Repurchase Program In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. The share repurchase program has been subsequently extended and increased, most recently in the second quarter of 2024.
Share Repurchase Program In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021.
Net cash used in investing activities was $36.7 million for 2023 which primarily consisted of $25.7 million for payments related to internally developed software to advance our Healthcare and Education software products; $9.4 million for purchases of property and equipment, 33 Table of Contents primarily related to purchases of computers and related equipment and leasehold improvements for certain office spaces; $3.1 million for contributions to our life insurance policies; and $1.6 million for the purchase of a business.
Net cash used in investing activities was $145.8 million for 2025 which primarily consisted of $111.6 million for purchases of businesses; $20.6 million for payments related to internally developed software to advance our Education and Healthcare software products; $10.4 million for purchases of property and equipment, primarily related to purchases of computers and related equipment and leasehold improvements for certain office spaces; and $3.2 million for contributions to our life insurance policies.
Unexpected changes in the demand for our services can result in significant variations in utilization and revenues and present a challenge to optimal hiring and staffing. Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.
Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.
Adjusted Net Income and Adjusted Earnings per Share Adjusted net income increased $24.2 million to $120.4 million for the year ended December 31, 2024, compared to $96.2 million for the year ended December 31, 2023.
Adjusted Net Income and Adjusted Earnings per Share Adjusted net income increased $20.4 million, or 16.9% , to $140.8 million for the year ended December 31, 2025, compared to $120.4 million for the year ended December 31, 2024.
We believe that these unrealized losses and gains are not indicative of the ongoing performance of our business and their exclusion permits comparability with prior periods.
These unrealized losses and gains are included as a component of other income (expense), net on our consolidated statement of operations. We believe these unrealized losses and gains are not indicative of the ongoing performance of our business and their exclusion permits comparability with prior periods.
These items are recorded as a component of other gains, net on our consolidated statement of operations. Transaction-related expenses : To permit comparability with prior periods, we exclude the impact of third-party advisory, legal, and accounting fees and other corporate costs incurred directly related to the evaluation and/or consummation of business acquisitions.
Transaction-related expenses : We exclude the impact of third-party advisory, legal, and accounting fees and other corporate costs incurred directly related to the evaluation and/or consummation of business acquisitions to permit comparability with prior periods as these costs are inconsistent in their amount and frequency and are significantly affected by the timing and size of our acquisitions.
Results for 2024 include an $11.1 million litigation settlement gain, net of tax, recognized in the second quarter of 2024 related to a completed legal matter in which Huron was the plaintiff. Results for 2023 include a non-cash impairment loss of $19.4 million, net of tax, related to our investment in a hospital-at-home company.
Results for 2025 include $7.7 million of non-cash impairment charges, net of tax, related to our convertible debt investment in a third-party. Results for 2024 include an $11.1 million litigation settlement gain, net of tax, related to a completed legal matter in which Huron was the plaintiff.
Healthcare operating margin increased to 27.6% from 25.7% primarily due to the decrease in contractor expenses; partially offset by an increase in practice administration and meetings expenses, as a percentage of revenues before reimbursable expenses. • Education operating income increased $9.4 million, or 9.5%, primarily due to the increase in revenues before reimbursable expenses as well as decreases in training expenses and contractor expenses; partially offset by increases in compensation costs for our revenue-generating professionals and support personnel and amortization of capitalized software development costs.
Healthcare operating margin increased to 30.5% from 27.6% primarily due to the decreases in salaries and related expenses for our support personnel, bad debt expense, and practice administration and meetings expenses, and revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals. • Education operating income increased $4.7 million, or 4.3%, primarily due to the increase in revenues before reimbursable expenses; partially offset by increases in compensation costs for our revenue-generating professionals and support personnel, amortization of internally developed software, contractor expenses, practice administration and meeting expenses, promotion and marketing expenses, and project costs.
RESULTS OF OPERATIONS Executive Highlights Highlights from the year ended December 31, 2024 include the following: • Revenues before reimbursable expenses increased 9.1% to $1.49 billion in 2024 from $1.36 billion in 2023. • Net income as a percentage of total revenues increased to 7.7% in 2024, compared to 4.5% in 2023. • Adjusted EBITDA as a percentage of revenues before reimbursable expenses increased to 13.5% in 2024 from 12.3% in 2023. • Diluted EPS increased 96.6% to $6.27 for 2024, compared to $3.19 for 2023.
RESULTS OF OPERATIONS Executive Highlights Highlights from the year ended December 31, 2025 include the following: • Revenues before reimbursable expenses increased 11.9% to $1.66 billion in 2025 from $1.49 billion in 2024. • Net income as a percentage of total revenues was 6.2% in 2025, compared to 7.7% in 2024.
See Note 3 “Acquisitions and Divestiture” within the notes to our consolidated financial statements for additional information on our acquisitions and Note 13 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on our contingent consideration liabilities.
Increases or decreases in the fair value of contingent consideration liabilities resulting from changes in the estimates or assumptions could materially impact the financial statements. 37 Table of Contents See Note 3 “Acquisitions and Divestiture” within the notes to our consolidated financial statements for additional information on our acquisitions and Note 13 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on our contingent consideration liabilities.
The number of Managed Services professionals increased 45.7% to 1,530 as of December 31, 2024 from 1,050 as of December 31, 2023.
The number of Managed Services professionals increased 46.3% to 2,239 as of December 31, 2025 from 1,530 as of December 31, 2024.
Our Consolidated Leverage Ratio as of December 31, 2024 was 1.39 to 1.00, compared to 1.59 to 1.00 as of December 31, 2023. Our Consolidated Interest Coverage Ratio as of December 31, 2024 was 10.50 to 1.00, compared to 10.85 to 1.00 as of December 31, 2023.
Our Consolidated Leverage Ratio as of December 31, 2025 was 1.93 to 1.00, compared to 1.39 to 1.00 as of December 31, 2024.
These non-GAAP financial measures are used by management in their 22 Table of Contents financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons.
Our management uses the non-GAAP financial measures to gain an understanding of our comparative operating performance, for example when comparing such results with previous periods or forecasts. These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons.
Education operating margin decreased to 22.9% from 23.1% primarily driven by an increase in salaries and related expenses for our revenue-generating professionals, as a percentage of revenues before reimbursable expenses; partially offset by the decrease in performance bonus expense for our revenue-generating professionals. • Commercial operating income decreased $3.0 million, or 5.5%, primarily due to the decrease in revenues before reimbursable expenses as well as increases in compensation costs for our revenue-generating professionals and software and data hosting expenses; partially offset by decreases in promotion and marketing expenses and restructuring charges.
Education operating margin decreased to 22.6% from 22.9% primarily driven by the increases in amortization of internally developed software, salaries and related expenses for our support personnel, contractor expenses, practice administration and meetings expenses, projects costs and promotion and marketing expenses, all as percentages of revenues before reimbursable expenses; partially offset by revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals and the decrease in performance bonus expense for our revenue-generating professionals. • Commercial operating income increased $4.7 million, or 9.1%, primarily due to the increase in revenues before reimbursable expenses, partially offset by increases in compensation costs for our revenue-generating professionals, contractor expenses, salaries and related expenses for our support personnel and restructuring charges.
The utilization rate within our Digital capability increased to 76.0% in 2024, compared to 75.3% in 2023. Our total number of revenue-generating professionals, excluding Managed Services professionals, increased 5.0% to 4,694 as of December 31, 2024, compared to 4,469 as of December 31, 2023, as a result of hiring to support the overall increase in demand for our services.
Our total number of revenue-generating professionals, excluding Managed Services professionals, increased 13.1% to 5,307 as of December 31, 2025, compared to 4,694 as of December 31, 2024, as a result of the acquisitions completed since December 31, 2024 and hiring to support the overall increase in demand for our services.
The $79.1 million increase in compensation costs reflects our investment to grow our talented team to meet increased market demand and is primarily attributable to a $76.7 million increase in salaries and related expenses driven by increased headcount and annual salary increases that went into effect in the first quarter of 2024 and a $5.5 million increase in performance bonus expense; partially offset by a $2.8 million decrease in signing, retention and other bonus expense.
The $99.0 million increase in compensation costs reflects our investment to grow our talented team to meet increased market demand and is primarily attributable to an $87.2 million increase in salaries and related expenses driven by the recent acquisitions, hiring to support the overall increase in demand for our services, and annual salary increases that went into effect in the first quarter of 2025, as well as a $6.3 million increase in performance bonus expense, a $4.4 million increase in signing, retention and other bonus expense, and a $1.0 million increase in share-based compensation expense.
The $67.4 million increase primarily related to a $79.1 million increase in compensation costs for our revenue-generating professionals and a $4.0 million increase in technology costs, partially offset by a $14.4 million decrease in contractor expenses.
The $112.4 million increase primarily related to a $99.0 million increase in compensation costs for our revenue-generating professionals, an $8.7 million increase in contractor expenses, and a $3.0 million increase in technology costs.
The borrowings and repayments during 2024 include the $275.0 million Term Loan proceeds which were used to repay borrowings under the Revolver in the first quarter of 2024. The net borrowings of $33.7 million were primarily used to fund our operations, including our annual performance bonus payments in the first quarter of 2024.
The borrowings and repayments during 2024 include the $275.0 million term loan proceeds received under the Existing Credit Agreement in the first quarter of 2024, which were used to repay borrowings under the revolver in the first quarter of 2024.
Operating income and operating margin for each of our segments as well as unallocated corporate expenses were as follows: Segment Operating Income (in thousands, except operating margin percentages) Year Ended December 31, Increase / (Decrease) 2024 2023 Healthcare $ 208,928 27.6% $ 172,900 25.7% $ 36,028 Education $ 108,521 22.9% $ 99,098 23.1% $ 9,423 Commercial $ 51,198 20.0% $ 54,202 21.0% $ (3,004) Unallocated Corporate Expenses (in thousands) Unallocated corporate expenses $ 191,180 $ 175,206 $ 15,974 • Healthcare operating income increased $36.0 million, or 20.8%, primarily due to the increase in revenues before reimbursable expenses and a decrease in contractor expenses; partially offset by increases in compensation costs for our revenue-generating professionals, practice administration and meetings expenses, technology costs, bad debt expense, and promotion and marketing expenses.
Operating income and operating margin for each of our segments as well as unallocated corporate expenses were as follows: Segment Operating Income (in thousands, except operating margin percentages) Year Ended December 31, Increase / (Decrease) 2025 2024 Healthcare $ 255,582 30.5% $ 208,928 27.6% $ 46,654 Education $ 113,186 22.6% $ 108,521 22.9% $ 4,665 Commercial $ 55,857 17.2% $ 51,198 20.0% $ 4,659 Unallocated Corporate Expenses (in thousands) Unallocated corporate expenses $ 217,564 $ 191,180 $ 26,384 • Healthcare operating income increased $46.7 million, or 22.3%, primarily due to the increase in revenues before reimbursable expenses, as well as decreases in salaries and related expenses for our support personnel, bad debt expense, and practice administration and meetings expenses; partially offset by increases in compensation costs for our revenue-generating professionals and technology expenses.
The Term Loan is subject to scheduled quarterly amortization payments of $3.4 million which began June 30, 2024 and continue through the maturity date of November 15, 2027, at which time the outstanding principal balance and all accrued interest will be due.
The Term Loan is subject to scheduled quarterly amortization payments of $5.0 million which began September 30, 2025 and continue through the maturity date of July 30, 2030, at which time the outstanding principal balance and all accrued interest will be due. The Amended Credit Agreement amended and restated the Existing Credit Agreement in its entirety.
The overall increase in revenues before reimbursable expenses reflects continued strength in demand for both our Consulting and Managed Services capability and Digital capability within our Healthcare and Education segments, and reflects our focus on accelerating growth in our healthcare and education industries.
The overall increase in revenues before reimbursable expenses reflects strength in demand for our Consulting and Managed Services capabilities within all three of our segments, as well as continued strength in demand for our Digital capabilities within our Commercial and Education segments.